By The Conversation 1h ago

Share this article:

By Sara Brown

Skin is our largest organ and something we may take for granted when its healthy. As an academic dermatologist I frequently hear misleading facts that seem to be stubbornly enduring. Here are some of the most commonly shared myths that can be cleared up immediately, and some truths you can rely on.

Skin constantly renews itself

TRUE: The skin provides a dynamic barrier between your bodys internal environment and the outside world. Cells called keratinocytes in the epidermis (the outer layer of skin) are constantly dividing to produce a supply of cells that move up through this layer and are shed from its surface. Skin is a rich source of stem cells with the capacity to divide and renew themselves.

Drink two litres of water a day for healthy skin

FALSE: The amount of water you drink does not directly affect your skin. Water is supplied to the skin by blood flowing through the dermis, the inner layer of skin; water is lost from the epidermis, especially in a dry environment.

Water is needed to maintain skin hydration and when you become seriously dehydrated your skin appears dull and is less elastic. In a healthy person the internal organs kidneys, heart and blood vessels control the amount of water reaching the skin. There is no fixed volume of water that you need to drink, it simply depends on the amounts you are using and losing.

Stress can make skin unhealthy

TRUE: There are many health issues in modern life that we blame on stress, but several skin conditions have been shown in scientific studies to be worsened by life events, possibly via stress hormones including cortisol (a steroid hormone made in the adrenal glands). Notable examples are alopecia areata, an auto-immune condition where the bodys immunity begins to attack the hair follicles, causing hair to fall out; psoriasis, another auto-immune condition that causes skin thickening, scaling and inflammation; and eczema, itchy red skin inflammation often occurring alongside asthma, hay fever and other allergies. Unfortunately a flare-up of these skin conditions is exactly what you dont need when you are feeling stressed or under pressure.

Eating chocolate causes acne

FALSE: Acne vulgaris, the common teenage acne which can actually persist into your thirties and forties, occurs as a result of the interaction between hormonal effects on grease glands in the skin, plus the skins immune response to blocked pores and microbes living on the skin.

Eating a high fat diet is unhealthy for many reasons, but it doesnt cause acne. In fact some tablets prescribed for severe acne such as oral isotretinoin are better absorbed when pills are swallowed with a fatty meal and that could include chocolate.

Washing powder causes eczema

FALSE: Eczema is a condition where the skin is dry, itchy and red. It is caused by a combination of genetic factors (how your skin is made) and environmental effects, leading to inflammation. Soap, detergents and washing powders can irritate the skin and contribute to dryness because they remove oil from the skin (just as washing-up liquid removes grease from your dishes). Biological washing powders contain enzymes proteins that break down fats and other proteins to remove stains and these can irritate sensitive skin, so they may worsen eczema. It is important that any washing power is thoroughly rinsed out of clothing before it is worn, to avoid skin irritation.

White marks on nails = calcium deficiency

FALSE: Nails are manufactured in the nail matrix, an area under the skin at the top edge of your nail. If the matrix is traumatised, bumped or bitten, an irregularity in the developing nail occurs and air can become trapped. This appears as a white mark as the nail grows out. Calcium is important for healthy nails (as well as bones and teeth) but these white marks are not a sign of deficiency.

Sunshine is good for you

TRUE & FALSE Many people have experienced the feel-good factor of a sunny day, but there are good and bad effects of sunlight. Light from the sun includes a mixture of different wavelengths of light: some are visible to the human eye, some are shorter than the colours we can see these are called ultraviolet (UV) and some are longer, the infrared. Different wavelengths have different effects on skin.

UVB is used by skin to manufacture vitamin D which is essential for bone health. Without sun exposure this vitamin must be obtained from the diet. Dermatologists use specific wavelengths of UVA and UVB in carefully controlled doses to reduce skin inflammation, a valuable treatment for some skin conditions.

But when the skin is exposed to too much UV it can damage the skin cells DNA, leading to uncontrolled growth the basis of cancer. As a simple rule, unless you have a disease or treatment that suppresses your immune system, sunshine is good for you in moderation, but always avoid getting sunburned.

Keep it simple

The basic principles of keeping skin healthy are mainly common sense. You should wash your skin regularly to remove dirt, but not so much that you remove the essential moisture and water-proofing substances. Use a moisturiser if your skin feels tight or dry a greasy ointment works best unless you have acne-prone skin, in which case you should use a non-greasy water-based cream. Avoid stress if possible, eat a healthy diet and drink water when you feel thirsty. And finally, protect your skin from too much sun with a hat and clothing or sunscreen.

The Conversation

See the article here:
7 misleading 'facts' about skin that just aren't true - IOL

The idea that anything branded skincare can be described as unusual (complex chemical compounds aside) is a minefield, running up against cultural contexts and personal preferences. Caviar-infused, charcoal-spiked, caffeine-boosted... the list can be endless. Sure, some of these may seem slightly familiar today, but over the years, creatures like snails, snakes and bees have inched their way from the outdoors to skincare concoctions. But are these bizarre additives actual glow givers or simply advertising gimmicks? To find out, we caught up with two experts, New York-based dermatologist Dr Joshua Zeichner and Ginger King, a cosmetic chemist from New Jersey, who uncover nine weird (yet seemingly wonderful) ingredients and the beauty payoff they offer. Plus, some lotions and potions worth checking out that feature them.

A distinctive type of algae species, red algae are mostly found in freshwater lakes. Besides being a natural food source for fish and other aquatic animals, this protein-rich, vitamin-laced algae is considered a delicacy in Japan and the North Atlantic. The University of California, Berkeley claims phycoerythrin (the pigment found in red algae) reflects red light and absorbs blue light. We already have enough research that prove millions of tiny particles of blue light travel from your smart devices down to the deepest level of your skin to decompose the collagen and elastin necessary to ward off wrinkles. Red algae contains high levels of carotenoid antioxidants, which not only gives the algae its red colour, but also protects the skin from free radical damage, explains Dr Zeichner, director of cosmetic and clinical research in the dermatology department at Mount Sinai Hospital in New York.

Find it in: Triple Algae Pollution Shield by Paulas Choice, Bobbi Brown Skin Relief No. 80 - Calming Algae Complex

Talk about an overachiever: this humble, single-celled fungi commonly used for baking breads and cinnamon rolls is also a potent anti-inflammatory ingredient, reveals King, who, with her innovative concepts and product formulations, has developed over hundreds of skin and haircare products. Yeast actually helps in healing burns too. Aveeno, for example, is based on beta glucan [sugars found in the cell walls of yeasts]. Yeast owes its anti-ageing attributes to peptide, which increases sirtuina type of protein that regulates collagen and elastin. Another major plus? Pitera, the liquid derived from the yeast fermentation process, is super-rich in vitamins, minerals, and amino acids that can strengthens skin's moisture barrier.

Find it in: The Renewal Oil by La Mer; SK-II Facial Treatment Essence

While theres a bevy of snail-slime skincare products by K-beauty brands that claims to be the quickest route to glass skin, Dr Zeichner, too, is bullish on the protein-rich, antioxidant-filled secretion cryptomphalus aspersa species aka the garden variety snail leave behind on sidewalks. Snails mucous has been shown to have antioxidant properties, stimulate collagen production, and enhance wound healing. It is also very rich, so it can help hydrate the skin. Clinical studies have shown that snail mucin containing skincare products gave sophistical improvements in facial lines and wrinkles, he goes on to reveal.

Find it in: SMD Saromae Snail Serum Concentrate; Benton Snail Bee High Content Essence

Squalene is found in high concentrations in shark liver. It is also present in our own sebum, so it is the most natural way to moisturise the skin, adds King. Squalene is a lipid or fat, naturally made by our oil glands to hydrate and maintain the barrier of our skin. It has also been known to fight free-radical damage as an antioxidant. Unfortunately, the squalene production significantly slows down after the age of 30, which is why it makes sense to slather it on the face. In its crude state, it is not a stable compound and thats why it goes through a saturation process to become squalane to be added to skincare products. Due to the obvious ethical reasons, it is now derived from plants like sugarcane, shares King. Squalanes emollient properties can be especially advantageous to people with dry and/or mature skin.

Find it in: The Ordinary 100% Plant-Derived Squalane; Youth to the People's Superberry Hydrate + Glow Dream Mask; Biossance Squalane + Peptide Eye Gel

No, this is not human bone marrow. Chicken bones is invariably the marrow of choice to derive glucosamine (the natural compound found in the tough tissue that cushions joints) for creams and moisturisers, or it is bioengineered from shells of shellfish. Stem cells, when applied on the skin, take cues from the surrounding tissue to generate new skin cells, and in turn, a younger-looking skin. Glucosamine has been shown to enhance collagen production and stimulate hyaluronic acid. This can help strengthen and plump the skin, says Dr Zeichner, reinstating the efficacy of glucosamine on skin ageing.

Find it in: Perfectionist Pro Rapid Firm + Lift Treatment with Acetyl Hexapeptide-8 by Este Lauder; Dermalogica AGE Smart Power Rich

Once upon a time, a Swedish chemist used diatomaceous earth (a type of a sedimentary rock) to patent a mixture called dynamite. A century and few decades later, this component used to make explosives was infused in skincare products, thanks to its inherent benefits to absorb oils, exfoliate the skin, reduce shine and trap bacteria. Diatomaceous earth is often used as a filler in powder masks as it helps to detoxify and draw out excess skin sebum, reveals King.

Find it in: Diatomamus Earth Mask by B. Kamins; Grand Central Beauty Mask

While we associate a bee sting with the opposite-of-magic (read: teeth-gnashing pain), the colourless, liquid poison a bee deposits from its stinger when it stings, in contrast, is thought to increase collagen production to thicken the skin and improve the appearance of wrinkles, shares Dr Zeichner. Turns out that the venom also boosts of powerful anti-inflammatory benefits to diminish those pesky pimples, including cystic and body acne, that go a bit beneath the surface.

Find it in: Nip + Fab Bee Sting Deluxe Body Souffl; Rodials entire Bee Venom skincare line; Miss Spa Bee Venom Plumping Sheet Mask; Heaven Skincare Bee Venom Mask

Meet the natural wonder that has been generating quite a buzz and transforming complexionsgoats milk. Milk has been used for centuries to infuse the skin and hair with proteins, calcium and vitamins. It is a natural source of lactic acid. This mean it can slough off dead skin cells, says King, but also warns of skin sensitivity issues that can be caused by milk and recommends patch test first. Goats milk is known for its moisture-boosting, skin-softening and gentle-exfoliating properties thats perfect for dry, tight or chapped skin.

Find it in: Kate Somerville Goat Milk De-Puffing Eye Balm

The placenta is a large sac-like organ that develops during pregnancy to provide the developing baby with food and oxygen. It eventually expelled from a mammals body after the birth. Ovine serum derived from sheep placenta is used in some facials and beauty products too, says Dr Zeichner. While theres not much research behind its efficacy, it is thought to be rich in proteins and other ingredients that stimulate collagen to brighten and tighten the skin. It may be useful in people who have sun damage.

Find it in: MZ Skin Rest & Revive Restorative Placenta & Stem Cell Night Serum; Biologique Recherche Srum Placenta

These are the 10 most Googled skincare ingredients of 2020

4 skincare ingredients that sound scary but are actually good for you

The 5 active ingredients you actually need in your skincare routine

Continued here:
Red algae and sheep placenta: 9 bizarre but effective skincare ingredients that actually work - VOGUE India

Globe Newswire

Dublin, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The "Photoelectric Sensor Market with COVID-19 Impact Analysis by Type (Through Beam, Retroreflective, Reflective), Range, Structure, Beam Source, Output, Application (Industrial Manufacturing, Food and Beverages) and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The photoelectric sensor market was valued at USD 1.4 billion in 2019 and is projected to reach USD 2.1 billion by 2025; it is expected to grow at a CAGR of 7.8% from 2020 to 2025. Major factors driving the growth of the photoelectric sensor market include extensive use of photoelectric sensors in different industries, increased adoption of retroreflective photoelectric sensors in various applications, and surged adoption of industrial robots across several regions. Based on type, the retroreflective segment held the largest share of the photoelectric sensor market in 2019. In 2019, the retroreflective segment held the largest share of the photoelectric sensor market, and this trend is projected to prevail during the forecast period. The growth of the retroreflective segment can be attributed to the rising use of retroreflective photoelectric sensors in industrial manufacturing and pharmaceuticals and medical applications. These sensors have simple wiring and optical axis adjustment controls, which enable their unaffected operations irrespective of the color or angle of the targeted objects. Retroreflective photoelectric sensors are used in pharmaceuticals and medical applications to avoid the empty packaging of tablets. Based on range, the 100 to 1,000 mm range segment held the largest share of the photoelectric sensor market in 2019. The 100 to 1,000 mm range segment held the largest share of the photoelectric sensor market in 2019 and is likely to exhibit a similar growth trend during the forecast period. The growth of this segment can be attributed to the increased demand for 100 to 1,000 mm photoelectric sensors from various end-use industries. These sensors can carry out long-range and short-range object detection, irrespective of their materials such as glass, metal, plastic, wood, and liquid. The 100 to 1,000 mm range photoelectric sensors are compact and cost-effective. Based on structure, the built-in amplifier segment held the largest share of the photoelectric sensor market in 2019. The built-in amplifier segment held the largest share of the photoelectric sensor market in 2019, and this trend is expected to continue during the forecast period. The growth of this segment can be attributed to the extensive use of built-in amplifier photoelectric sensors in ICs and wafer detection applications in the semiconductor manufacturing process. Moreover, these sensors are used for the reliable detection of objects in the long-range with less effect of curve and gloss on their sensing capabilities. Built-in amplifier photoelectric sensors are used in industrial manufacturing and automotive applications. The fiber type segment of the market is projected to grow at the highest CAGR of 9.4% during the forecast period. The growth of this segment can be attributed to the ability of fiber type photoelectric sensors to detect small differences in the height of objects. The use of fiber type photoelectric sensors is limited to narrow-space applications. Based on the application, the industrial manufacturing applications held the largest market share in 2019. In 2019, the industrial manufacturing segment held the largest share of the photoelectric sensor market. The advent of Industry 4.0, automation robots, virtual reality, and augmented reality to make manufacturing easy and risk-free has led to the adoption of photoelectric sensors in various industries. The modernization of machinery and other manufacturing systems to ensure less human interference are also driving the growth of the photoelectric sensor market. The food and beverage segment of the market is projected to grow at the highest CAGR during the forecast period. The growing focus of the food and beverage industry on technologies and mechanical manipulation of raw foods to create high value-added food products is fueling the demand for photoelectric sensors. Moreover, automation brings standardization in all packaged food items and beverages. It minimizes human interference, thereby eliminating the chances of contamination of food and ensuring that all health standards are met. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Growth Opportunities in Photoelectric Sensor Market4.2 Photoelectric Sensor Market, by Type4.3 Photoelectric Sensor Market, by Geography4.4 Photoelectric Sensor Market, by Application and Region5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Extensive Use of Photoelectric Sensors in Different Industries5.2.1.2 Increased Adoption of Retroreflective Photoelectric Sensors in Various Applications5.2.1.3 Surged Adoption of Industrial Robots Across Several Regions5.2.2 Restraints5.2.2.1 Us-China Trade War5.2.2.2 Easy Availability of Competent Alternative Sensors5.2.3 Opportunities5.2.3.1 Increasing Demand for Photoelectric Sensors for Packaging Applications from Food and Beverages Industry5.2.3.2 Ongoing Digitization and Emerging Connected Industries5.2.3.3 Prevailing Trend of Miniaturized Sensors5.2.4 Challenges5.2.4.1 Unavailability of Raw Materials5.2.4.2 High Maintenance Costs of Photoelectric Sensors5.3 Revenue Shift and New Revenue Pockets for Photoelectric Sensor Market5.4 Photoelectric Sensor Ecosystem5.5 Asp Trend Analysis for Photoelectric Sensors5.6 Value Chain Analysis5.7 Government Regulations and Standards Related to Photoelectric Sensors5.8 Technologies Used in Photoelectric Sensors5.8.1 Key Technologies5.8.1.1 Cmos Technology5.8.1.2 Durabeam Technology5.8.1.3 Multi Pixel Technology (Mpt)5.9 Patent Analysis5.10 Use Cases for Photoelectric Sensors5.10.1 Use of Photoelectric Sensors Offered by Sick AG with Machines of Heye International GmbH for Glass Bottle Counting5.10.2 Adoption of Photoelectric Sensors of Ifm Electronic GmbH for Detecting Position of Stators6 Impact of COVID-19 on Photoelectric Sensor Market7 Photoelectric Sensor Market, by Type7.1 Introduction7.2 Through-Beam Photoelectric Sensors7.2.1 Through-Beam Photoelectric Sensors Offer Longest and Most Accurate Sensing Range7.2.2 Retroreflective Photoelectric Sensors7.2.2.1 Retroreflective Photoelectric Sensors Work Best for Transparent Products7.2.3 Reflective Photoelectric Sensors7.2.3.1 Cost-Effectiveness and Ease of Installation of Reflective Photoelectric Sensors Lead to Their Increased Global Demand8 Photoelectric Sensor Market, by Range8.1 Introduction8.2 ?100 Mm8.2.1 Increased Demand for ?100 Mm Photoelectric Sensors for Close Monitoring of Small Objects8.3 100 to 1,000 Mm8.3.1 100 to 1,000 Mm Segment Held Largest Share of Photoelectric Sensor Market in 20198.4 1,000 to 10,000 Mm8.4.1 Surged Adoption of 1,000 to 10,000 Mm Range Photoelectric Sensors in Food and Beverages and Packaging Applications8.5 >10,000 Mm8.5.1 Increased Use of >10,000 Mm Range Photoelectric Sensors in Transportation and Building Automation Applications9 Photoelectric Sensor Market, by Structure9.1 Introduction9.2 Built-In Amplifier9.2.1 Built-In Amplifier Segment Held Largest Share of Photoelectric Sensor Market in 20199.3 Built-In Power Supply9.3.1 Surged Adoption of Photoelectric Sensors with Built-In Power Supply in Noise-Free Applications and Compact Devices9.4 Separate Amplifier9.4.1 Increased Use of Separate Amplifier Photoelectric Sensors in Applications with Space Constraints9.5 Fiber Type9.5.1 Excellent Resistance Offered by Fiber Type Photoelectric Sensors to Harsh Environmental Conditions10 Photoelectric Sensor Market, by Beam Source10.1 Introduction10.2 Laser Beam Source10.2.1 Increased Demand for Long-Range and Highly Accurate Laser Beam Source Photoelectric Sensors10.3 Standard Beam Source10.3.1 Infrared10.3.1.1 High Efficiency of Infrared Sensors Drive Their Global Demand10.3.2 Led10.3.2.1 Led Segment Held Large Share of Standard Beam Source Photoelectric Sensor Market in 201911 Photoelectric Sensor Market, by Output11.1 Introduction11.2 Digital11.2.1 Digital Output Segment of Photoelectric Sensor Market to Grow at High CAGR from 2020 to 202511.3 Analog11.3.1 Risen Demand for Analog Output Photoelectric Sensors to Analyze Variations in Current Measurements12 Photoelectric Sensor Market, by Application12.1 Introduction12.2 Consumer Electronics12.2.1 Replacement of Mechanical Buttons and Switches in Consumer Electronics with Sleek and Robust Photoelectric Sensor Touch Interfaces12.3 Industrial Manufacturing12.3.1 Industrial Manufacturing Segment to Account for Largest Share of Photoelectric Sensor Market in 202512.4 Automotive and Transportation12.4.1 Surged Demand for Photoelectric Sensors in Automotive and Transportation Application to Adhere to Changing Government Norms and Standards12.5 Building Automation12.5.1 Increased Number of Smart City Initiatives and Adoption of Photoelectric Sensors in Building Automation Solutions12.6 Food and Beverages12.6.1 Food and Beverages Segment of Photoelectric Sensor Market to Grow at Highest CAGR from 2020 to 202512.7 Pharmaceuticals and Medical12.7.1 Increased Adoption of Photoelectric Sensors in Pharmaceuticals and Medical Applications for Accurate Liquid Level Detection and Tablet Counts12.8 Packaging12.8.1 Surged Use of Photoelectric Sensors in Packaging Plants to Track Transparent Packages and Count Pet Bottles12.9 Others13 Geographic Analysis13.1 Introduction13.2 North America13.3 Europe13.4 APAC13.5 Row14 Competitive Landscape14.1 Introduction14.2 Market Ranking Analysis of Players in Photoelectric Sensor Market, 201914.3 Market Evaluation Framework14.3.1 Product Launches and Developments14.3.2 Expansions, Partnerships, Acquisitions, and Joint Ventures14.3.3 Agreements and Collaborations14.4 Revenue Analysis of Top Market Players15 Company Evaluation Matrix15.1 Overview15.2 Company Evaluation Matrix Definition and Methodology15.2.1 Market Share/Ranking15.2.2 Star15.2.3 Pervasive15.2.4 Emerging Leader15.3 Company Evaluation Matrix (Global)15.4 Small and Medium-Sized Enterprises Evaluation Matrix15.5 Strength of Product Portfolio15.6 Business Strategy Excellence16 Company Profiles16.1 Key Players16.1.1 Omron Corporation16.1.2 Keyence Corporation16.1.3 Sick Ag16.1.4 Schneider Electric16.1.5 Rockwell Automation Inc.16.1.6 Ifm Electronic GmbH16.1.7 Pepperl+Fuchs16.1.8 Balluff Inc.16.1.9 Banner Engineering16.1.10 Panasonic Corporation16.2 Right to Win16.3 Other Key Players16.3.1 Sensopart Industriesensorik GmbH16.3.2 Htm Sensors16.3.3 Fargo Controls Inc.16.3.4 Eaton Corporation16.3.5 Leuze Electronic GmbH + Co. Kg16.3.6 Wenglor Sensoric16.3.7 Autonics Corporation16.3.8 Bernstein Ag16.3.9 CNTD Electric Technology Co. Ltd.16.3.10 Hans Turck GmbH & Co. Kg.16.3.11 Carlo Gavazzi Holding Ag17 Appendix For more information about this report visit https://www.researchandmarkets.com/r/72eyae Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

View original post here:
Alstom SA: Availability of the half-year financial report as at 30 September 2020 - Yahoo Finance UK

Stem cells are biological cells which have the ability to distinguish into specialized cells, which are capable of cell division through mitosis. Amniotic fluid stem cells are a collective mixture of stem cells obtained from amniotic tissues and fluid. Amniotic fluid is clear, slightly yellowish liquid which surrounds the fetus during pregnancy and is discarded as medical waste during caesarean section deliveries. Amniotic fluid is a source of valuable biological material which includes stem cells which can be potentially used in cell therapy and regenerative therapies. Amniotic fluid stem cells can be developed into a different type of tissues such as cartilage, skin, cardiac nerves, bone, and muscles. Amniotic fluid stem cells are able to find the damaged joint caused by rheumatoid arthritis and differentiate tissues which are damaged.

For more insights into the Market, request a sample of this report @https://www.persistencemarketresearch.com/samples/23101

Medical conditions where no drug is able to lessen the symptoms and begin the healing process are the major target for amniotic fluid stem cell therapy. Amniotic fluid stem cells therapy is a solution to those patients who do not want to undergo surgery. Amniotic fluid has a high concentration of stem cells, cytokines, proteins and other important components. Amniotic fluid stem cell therapy is safe and effective treatment which contain growth factor helps to stimulate tissue growth, naturally reduce inflammation. Amniotic fluid also contains hyaluronic acid which acts as a lubricant and promotes cartilage growth.

With increasing technological advancement in the healthcare, amniotic fluid stem cell therapy has more advantage over the other therapy. Amniotic fluid stem cell therapy eliminates the chances of surgery and organs are regenerated, without causing any damage. These are some of the factors driving the growth of amniotic fluid stem cell therapy market over the forecast period. Increasing prevalence of chronic diseases which can be treated with the amniotic fluid stem cell therapy propel the market growth for amniotic fluid stem cell therapy, globally. Increasing funding by the government in research and development of stem cell therapy may drive the amniotic fluid stem cell therapy market growth. But, high procedure cost, difficulties in collecting the amniotic fluid and lack of reimbursement policies hinder the growth of amniotic fluid stem cell therapy market.

For Information On The Research Methodology request here @https://www.persistencemarketresearch.com/methodology/23101

The global amniotic fluid stem cell therapy market is segmented on basis of treatment, application, end user and geography:

To receive extensive list of important regions, Request TOC here @https://www.persistencemarketresearch.com/toc/23101

Rapid technological advancement in healthcare, and favorable results of the amniotic fluid stem cells therapy will increase the market for amniotic fluid stem cell therapy over the forecast period. Increasing public-private investment for stem cells in managing disease and improving healthcare infrastructure are expected to propel the growth of the amniotic fluid stem cell therapy market.

However, on the basis of geography, global Amniotic Fluid Stem Cell Therapy Market is segmented into six key regionsviz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. North America captured the largest shares in global Amniotic Fluid Stem Cell Therapy Market and is projected to continue over the forecast period owing to technological advancement in the healthcare and growing awareness among the population towards the new research and development in the stem cell therapy. Europe is expected to account for the second largest revenue share in the amniotic fluid stem cell therapy market. The Asia Pacific is anticipated to have rapid growth in near future owing to increasing healthcare set up and improving healthcare expenditure. Latin America and the Middle East and Africa account for slow growth in the market of amniotic fluid stem cell therapy due to lack of medical facilities and technical knowledge.

Some of the key players operating in global amniotic fluid stem cell therapy market are Stem Shot, Provia Laboratories LLC, Thermo Fisher Scientific Inc. Mesoblast Ltd., Roslin Cells, Regeneus Ltd. etc. among others.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Originally posted here:
The Amniotic Fluid Stem Cell Therapy market to be in conjunction to growth from 2018 to 2026 - PRnews Leader

LA JOLLA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced financial results for the third quarter 2020.

Read more from the original source:
Equillium Reports Third Quarter 2020 Financial Results and Business Highlights

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it plans to release 12-month data for Groups 1 through 4 evaluating durability of effect and continued safety and interim data of Groups 5 and 6 evaluating safety and efficacy at higher doses for its Phase 1/2 clinical trial in patients with X-linked Retinitis Pigmentosa (XLRP) on November 11, 2020. AGTC management will host a conference call and webcast with accompanying slides to review the data and provide a general update on the XLRP trial beginning at 8:00am Eastern Time on the same date.

View post:
AGTC to Host Conference Call on November 11 at 8:00 am ET to Discuss XLRP 12-Month Data and Full 6-Month Data from Highest Dose Groups of its Ongoing...

FLORHAM PARK, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported financial results for the third quarter of 2020 and provided an update of its ongoing pivotal Phase 3 trials for vonoprazan.

Go here to see the original:
Phathom Pharmaceuticals Reports Third Quarter 2020 Results and Provides Update on Phase 3 Trials

Topline Data for HST-001 Phase 1b/2a Trial for Androgenic Alopecia in Men on Track for 4Q20

See the original post:
Histogen Reports Third Quarter 2020 Earnings and Provides Business Update

NEWTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2020, and provided an update on the Company’s recent corporate developments.

View post:
Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

GUILFORD, Conn., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC–Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announces details of its forthcoming Annual General Meeting (“the Meeting”) of shareholders. The Meeting will be held at the offices of Marcum LLP, 555 Long Wharf Dr. 8th floor, New Haven, CT 06511, USA, on Thursday December 10, 2020 at 9:00 a.m. (Eastern standard time).

See original here:
Bioasis Announces Annual General Meeting Details

TEMPLE CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that its Chief Financial Officer Paul Kim and Chief Commercial Officer Brandon Perthuis are scheduled to virtually participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on Wednesday, November 11, 2020. These representatives of the company will host a presentation beginning at 3:30 p.m. ET.

Read the rest here:
Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference

- Initiation of Phase 1/2a Trial of CLS-AX (axitinib injectable suspension) for Wet Age-Related Macular Degeneration Expected by Year-End 2020 -- Phase 2 Trials Using SCS Microinjector® Ongoing by Gene Therapy and Oncology Partners -- Management to Host Webcast and Conference Call Today at 4:30 P.M. ET -

More:
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update

PLEASANTON, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2020.

See original here:
10x Genomics Reports Third Quarter 2020 Financial Results

Company to host conference call and webcast today, November 10, at 4:30pm ET Company to host conference call and webcast today, November 10, at 4:30pm ET

See the original post here:
Eyenovia Reports Third Quarter 2020 Financial Results

SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended September 30, 2020.

Link:
Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results

SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced a collaboration with GlaxoSmithKline plc (GSK) to use its clonoSEQ® Assay to assess minimal residual disease (MRD) in GSK’s portfolio of hematology products.

Read more:
Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology...

Company to host investor conference call and webcast today at 5:00 pm EST Company to host investor conference call and webcast today at 5:00 pm EST

See the original post here:
Viela Bio Reports Third Quarter 2020 Financial Results and Program Highlights

BOULDER, Colo., Nov. 10, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a biotechnology company advancing new treatments for patients with diseases that are underserved by current therapies, today announced financial results for the third quarter ended September 30, 2020 and provided corporate updates.

Link:
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today provided a business update and reported financial results for the third quarter of 2020.

Excerpt from:
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results

BRIDGEWATER, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Clinical Genomics (“CG” or the “Company”), a provider of colorectal cancer diagnostic solutions, including liquid biopsy tests, today announced that Betsy Hanna, Chief Executive Officer, will present at the 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum as follows:

Read more here:
Clinical Genomics to Present at 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum